---
title: "SNELLGROVE DARREN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8e882913-7dc2-5267-a135-ef47bcdf1930
json: https://whiteintel.dev/api/public/dossier/8e882913-7dc2-5267-a135-ef47bcdf1930
identifier: sec:0002137401
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SNELLGROVE DARREN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002137401`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8e882913-7dc2-5267-a135-ef47bcdf1930  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8e882913-7dc2-5267-a135-ef47bcdf1930  

## Ownership & control

### Holdings / subsidiaries

- **HALOZYME THERAPEUTICS, INC.** (officer) — https://whiteintel.dev/entity/69cc61fe-9e71-5735-ab26-f3a37dc83892

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SNELLGROVE DARREN**. Human view: https://whiteintel.dev/entity/8e882913-7dc2-5267-a135-ef47bcdf1930 · Structured JSON: https://whiteintel.dev/api/public/dossier/8e882913-7dc2-5267-a135-ef47bcdf1930._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._